Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs low-dose bivalirudin during elective PCI in acute coronary syndrome
ChiCTR2200064363Phase 4Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Oct 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of bivalirudin in acute coronary syndrome (ACS) (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Net adverse clinical events. Started Oct 2022; status: recruiting.
02
Drugs
bivalirudin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR2200064363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064363.